A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update
COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based...
Saved in:
Published in | BMC infectious diseases Vol. 21; no. 1; pp. 906 - 7 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
03.09.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids.
A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis.
Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. |
---|---|
AbstractList | Abstract Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids.BACKGROUNDCOVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids.A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis.CASE PRESENTATIONA 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis.Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.CONCLUSIONOur report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. Keywords: COVID-19, Mucormycosis, Rhizopus oryzae |
ArticleNumber | 906 |
Audience | Academic |
Author | Hemmat, Nima Safari, Shapoor Mohammadi, Faezeh Badri, Milad |
Author_xml | – sequence: 1 givenname: Faezeh orcidid: 0000-0002-9822-2626 surname: Mohammadi fullname: Mohammadi, Faezeh – sequence: 2 givenname: Milad orcidid: 0000-0002-1860-326X surname: Badri fullname: Badri, Milad – sequence: 3 givenname: Shapoor surname: Safari fullname: Safari, Shapoor – sequence: 4 givenname: Nima surname: Hemmat fullname: Hemmat, Nima |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34479495$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk9tu1DAQhiNURA_wAlwgS9zARUp8ShwukKpyWqnSShx6a02cydZVEi-209I34LFxui3arRBCvrBlf_8_9njmMNsb3YhZ9pwWx5Sq8k2gTFV1XjCaF2XJZM4fZQdUVDRnnIu9rfV-dhjCZVHQSrH6SbbPhahqUcuD7NcJMRCQeFw7H4nriL-wo8s7MBZ6MkzG-eHGuGADsSMBku6QtxYajNaQNUSLYyTXNl6Q0-X54n1O67eJCjch4gAz4_HK4vXs3NuIHuLkkcDYEjN5P4undQsRn2aPO-gDPrubj7LvHz98O_2cny0_LU5PznJTchpz03SoUJmmLVvRSENlYzpoK15BUzFKjQHKqo4LWSB2KMv5nJUAShSSIeNH2WLj2zq41GtvB_A32oHVtxvOrzT4dO8edQqAtO7qVolSKMkVFKwSKKkqGlUwTF7vNl7rqRmwNek1Hvod092T0V7olbvSSlBZ1jIZvLoz8O7HhCHqwQaDfQ8juiloliiuGC9pQl8-QC_d5MeUqkRV6T9prbaoFaQH2LFzKa6ZTfVJWUnGGZUiUcd_odJocbAmFVln0_6O4PWOIDERf8YVTCHoxdcv_88uz3fZF9sJ_JO5-_pMgNoAxrsQPHba2JjKys35tL2mhZ5bQW9aQadW0LetoHmSsgfSe_d_iH4Dqz0JiQ |
CitedBy_id | crossref_primary_10_1371_journal_pone_0271333 crossref_primary_10_1016_j_mehy_2021_110748 crossref_primary_10_1016_j_identj_2022_02_010 crossref_primary_10_1007_s00774_022_01330_w crossref_primary_10_1007_s40278_022_13796_7 crossref_primary_10_1159_000536370 crossref_primary_10_1080_01676830_2023_2186435 crossref_primary_10_1007_s11033_021_07085_3 crossref_primary_10_1007_s15010_023_02147_z crossref_primary_10_1016_j_radcr_2022_05_049 crossref_primary_10_3390_jof8070756 crossref_primary_10_4103_jfmpc_jfmpc_2401_21 crossref_primary_10_4103_jmau_jmau_81_23 crossref_primary_10_1007_s00284_023_03430_w crossref_primary_10_7759_cureus_24986 crossref_primary_10_29333_ejmds_11973 crossref_primary_10_36106_gjra_4202353 crossref_primary_10_1055_s_0042_1751003 crossref_primary_10_4103_ijpm_ijpm_792_22 crossref_primary_10_4103_jomfp_jomfp_236_24 |
Cites_doi | 10.4103/ijo.IJO_1053_21 10.1017/S0022215121000992 10.1111/tid.13652 10.1007/s11908-012-0272-6 10.18203/issn.2454-5929.ijohns20211583 10.3389/fmed.2021.645270 10.21203/rs.3.rs-533347/v1 10.2807/1560-7917.ES.2021.26.23.2100510 10.4103/ijo.IJO_3763_20 10.1016/j.idcr.2021.e01172 10.3390/jof7020088 10.1002/alr.22785 10.1016/S1473-3099(19)30312-3 10.1016/j.mycmed.2021.101125 10.1007/s12281-019-0337-1 10.1016/j.neurad.2021.05.007 10.1016/j.idnow.2021.01.010 10.1016/j.diabet.2012.01.002 10.1016/j.ijmmb.2021.05.009 10.1111/myc.13256 10.4103/ijo.IJO_3774_20 10.1016/j.radcr.2020.09.026 10.3390/jof6040265 10.22551/2020.28.0703.10172 10.1016/j.ijscr.2021.105957 10.21203/rs.3.rs-398594/v2 10.1016/S2666-5247(20)30115-4 10.1111/myc.13334 10.1016/S0030-6665(00)80010-9 10.5694/mja2.50674 10.14740/jmc3637 10.1016/j.cmi.2020.09.025 10.1016/j.ajem.2021.01.074 10.1136/bcr-2021-241663 10.1016/j.cmi.2019.11.021 10.1097/IOP.0000000000001889 10.1177/11206721211009450 10.1067/mhn.2002.126587 10.1016/j.cmi.2020.07.047 10.1093/cid/cir866 10.3390/jof7030174 10.5946/ce.2020.180 10.1007/s12070-021-02574-0 10.1111/tid.13663 |
ContentType | Journal Article |
Copyright | 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU COVID DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12879-021-06625-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Opposing Viewpoints (Gale in Context) Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
EndPage | 7 |
ExternalDocumentID | oai_doaj_org_article_d4be19f9d84648538a0274e5180b802e PMC8415695 A675232154 34479495 10_1186_s12879_021_06625_3 |
Genre | Systematic Review Journal Article Case Reports |
GeographicLocations | Iran United Kingdom--UK |
GeographicLocations_xml | – name: Iran – name: United Kingdom--UK |
GrantInformation_xml | – fundername: Qazvin University of Medical Sciences grantid: IR.QUMS.REC.1399.357 – fundername: ; grantid: IR.QUMS.REC.1399.357 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QL 7T2 7U9 7XB 8FK AZQEC C1K COVID DWQXO H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c631t-cbfe8e8cbd6d4b5c15bcfad737ab7211cca127f3450eefe565bcf26aa84052e23 |
IEDL.DBID | M48 |
ISSN | 1471-2334 |
IngestDate | Wed Aug 27 01:29:31 EDT 2025 Thu Aug 21 18:30:57 EDT 2025 Tue Aug 05 11:09:52 EDT 2025 Fri Jul 25 06:07:53 EDT 2025 Tue Jun 17 21:03:15 EDT 2025 Tue Jun 10 20:49:26 EDT 2025 Fri Jun 27 04:09:20 EDT 2025 Fri Jun 27 04:18:44 EDT 2025 Thu Jan 02 22:39:47 EST 2025 Thu Apr 24 23:00:10 EDT 2025 Tue Jul 01 01:57:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 Mucormycosis Rhizopus oryzae |
Language | English |
License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c631t-cbfe8e8cbd6d4b5c15bcfad737ab7211cca127f3450eefe565bcf26aa84052e23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Report-3 ObjectType-Case Study-4 ObjectType-Case Study-2 ObjectType-Feature-4 content type line 23 ObjectType-Undefined-5 ObjectType-Report-1 ObjectType-Article-3 |
ORCID | 0000-0002-9822-2626 0000-0002-1860-326X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-021-06625-3 |
PMID | 34479495 |
PQID | 2574471981 |
PQPubID | 42582 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d4be19f9d84648538a0274e5180b802e pubmedcentral_primary_oai_pubmedcentral_nih_gov_8415695 proquest_miscellaneous_2569382361 proquest_journals_2574471981 gale_infotracmisc_A675232154 gale_infotracacademiconefile_A675232154 gale_incontextgauss_ISR_A675232154 gale_incontextgauss_IOV_A675232154 pubmed_primary_34479495 crossref_citationtrail_10_1186_s12879_021_06625_3 crossref_primary_10_1186_s12879_021_06625_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-09-03 |
PublicationDateYYYYMMDD | 2021-09-03 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | YP Talmi (6625_CR8) 2002; 127 6625_CR28 6625_CR27 6625_CR29 LO Dallalzadeh (6625_CR35) 2021; 1 F Mohammadi (6625_CR6) 2018; 47 M Sen (6625_CR15) 2021; 69 A Khatri (6625_CR42) 2021; 187 S Sarkar (6625_CR16) 2021; 69 D Pasero (6625_CR52) 2020; 16 S Mehta (6625_CR12) 2020; 12 A Patel (6625_CR58) 2020; 26 A Moorthy (6625_CR14) 2021; 73 6625_CR20 OA Cornely (6625_CR5) 2019; 19 C Zurl (6625_CR49) 2021; 7 6625_CR25 C Arana (6625_CR47) 2021; 89 MN Gamaletsou (6625_CR4) 2012; 14 B Rammaert (6625_CR54) 2012; 38 S Sharma (6625_CR17) 2021; 135 DA Placik (6625_CR37) 2020; 15 L Szarpak (6625_CR2) 2021 S Challa (6625_CR10) 2019; 13 N Bayram (6625_CR32) 2021; 1 HA Farid (6625_CR53) 2021; 6 6625_CR50 BJ Ferguson (6625_CR9) 2000; 33 PG Gibson (6625_CR1) 2020; 213 R Rao (6625_CR23) 2021; 69 HS Meshram (6625_CR24) 2021; 2021 6625_CR55 TM Rawson (6625_CR56) 2021; 27 6625_CR57 A Werthman-Ehrenreich (6625_CR36) 2021; 42 B Hanley (6625_CR46) 2020; 1 do Monte Junior ES (6625_CR48) 2020; 53 V Krishna (6625_CR45) 2021; 23 S Waizel-Haiat (6625_CR51) 2021; 13 G Petrikkos (6625_CR7) 2012; 54 A Skiada (6625_CR11) 2020; 6 N Mishra (6625_CR19) 2021; 7 K Alekseyev (6625_CR39) 2021; 12 MM Ashour (6625_CR33) 2021 SM Revannavar (6625_CR18) 2021; 14 AK Johnson (6625_CR40) 2021; 32 M Helleberg (6625_CR3) 2021; 27 YA Fouad (6625_CR34) 2021; 8 A Kanwar (6625_CR41) 2021; 7 FAM Sargin (6625_CR31) 2021; 12 A Maini (6625_CR21) 2021; 82 ZK Mekonnen (6625_CR38) 2021; 37 N Khan (6625_CR43) 2020; 7 D Garg (6625_CR13) 2021; 19 HR Nehara (6625_CR22) 2021; 39 6625_CR30 JB Buil (6625_CR44) 2021; 26 M Karimi-Galougahi (6625_CR26) 2021; 1 |
References_xml | – volume: 69 start-page: 1627 issue: 6 year: 2021 ident: 6625_CR23 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_1053_21 – volume: 6 start-page: 1369 issue: 5 year: 2021 ident: 6625_CR53 publication-title: J Glob Sci Res – volume: 135 start-page: 442 issue: 5 year: 2021 ident: 6625_CR17 publication-title: J Laryngol Otol doi: 10.1017/S0022215121000992 – ident: 6625_CR55 – volume: 89 start-page: e13652 year: 2021 ident: 6625_CR47 publication-title: Transpl Infect Dis doi: 10.1111/tid.13652 – volume: 14 start-page: 423 issue: 4 year: 2012 ident: 6625_CR4 publication-title: Curr Infect Dis Rep doi: 10.1007/s11908-012-0272-6 – volume: 7 start-page: 867 issue: 5 year: 2021 ident: 6625_CR19 publication-title: Int J Otorhinolaryngol Head Neck Surg doi: 10.18203/issn.2454-5929.ijohns20211583 – volume: 8 start-page: 1 year: 2021 ident: 6625_CR34 publication-title: Front Medicine doi: 10.3389/fmed.2021.645270 – volume: 1 start-page: 1 year: 2021 ident: 6625_CR35 publication-title: Orbit – ident: 6625_CR57 doi: 10.21203/rs.3.rs-533347/v1 – volume: 26 start-page: 2100510 issue: 23 year: 2021 ident: 6625_CR44 publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2021.26.23.2100510 – volume: 69 start-page: 1002 issue: 4 year: 2021 ident: 6625_CR16 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_3763_20 – volume: 73 start-page: 1 year: 2021 ident: 6625_CR14 publication-title: J Maxillofac Oral Surg – volume: 23 start-page: e01172 year: 2021 ident: 6625_CR45 publication-title: IDCases doi: 10.1016/j.idcr.2021.e01172 – volume: 7 start-page: 88 issue: 2 year: 2021 ident: 6625_CR49 publication-title: J Fungi doi: 10.3390/jof7020088 – volume: 1 start-page: 1029 year: 2021 ident: 6625_CR26 publication-title: Int Forum Allergy Rhinol doi: 10.1002/alr.22785 – volume: 1 start-page: 1 year: 2021 ident: 6625_CR32 publication-title: Jpn J Ophthalmol – volume: 19 start-page: e405 issue: 12 year: 2019 ident: 6625_CR5 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(19)30312-3 – volume: 187 start-page: 101125 year: 2021 ident: 6625_CR42 publication-title: J Med Mycol doi: 10.1016/j.mycmed.2021.101125 – volume: 13 start-page: 11 issue: 1 year: 2019 ident: 6625_CR10 publication-title: Current Fungal Infection Reports doi: 10.1007/s12281-019-0337-1 – volume: 42 start-page: e265 issue: 264 year: 2021 ident: 6625_CR36 publication-title: Am J Emerg Med – year: 2021 ident: 6625_CR33 publication-title: J Neuroradiol doi: 10.1016/j.neurad.2021.05.007 – ident: 6625_CR50 doi: 10.1016/j.idnow.2021.01.010 – volume: 47 start-page: 994 issue: 7 year: 2018 ident: 6625_CR6 publication-title: Iran J Public Health – volume: 38 start-page: 193 issue: 3 year: 2012 ident: 6625_CR54 publication-title: Diab Metab doi: 10.1016/j.diabet.2012.01.002 – volume: 39 start-page: 380 issue: 3 year: 2021 ident: 6625_CR22 publication-title: Indian J Med Microbiol doi: 10.1016/j.ijmmb.2021.05.009 – ident: 6625_CR27 doi: 10.1111/myc.13256 – volume: 69 start-page: 244 issue: 2 year: 2021 ident: 6625_CR15 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_3774_20 – volume: 13 start-page: 1 issue: 2 year: 2021 ident: 6625_CR51 publication-title: Cureus – volume: 15 start-page: 2378 issue: 11 year: 2020 ident: 6625_CR37 publication-title: Radiol Case Rep doi: 10.1016/j.radcr.2020.09.026 – volume: 32 start-page: 64 year: 2021 ident: 6625_CR40 publication-title: Med Mycol – volume: 6 start-page: 265 issue: 4 year: 2020 ident: 6625_CR11 publication-title: J Fungi doi: 10.3390/jof6040265 – volume: 7 start-page: 2027 issue: 3 year: 2020 ident: 6625_CR43 publication-title: Arch Clin Cases doi: 10.22551/2020.28.0703.10172 – volume: 82 start-page: 105957 year: 2021 ident: 6625_CR21 publication-title: Int J Surg Case Rep doi: 10.1016/j.ijscr.2021.105957 – ident: 6625_CR28 doi: 10.21203/rs.3.rs-398594/v2 – volume: 1 start-page: e245 issue: 6 year: 2020 ident: 6625_CR46 publication-title: Lancet Microbe doi: 10.1016/S2666-5247(20)30115-4 – ident: 6625_CR30 doi: 10.1111/myc.13334 – volume: 12 start-page: 386 year: 2021 ident: 6625_CR31 publication-title: J Bacteriol Parasitol – volume: 33 start-page: 349 issue: 2 year: 2000 ident: 6625_CR9 publication-title: Otolaryngol Clin N Am doi: 10.1016/S0030-6665(00)80010-9 – ident: 6625_CR25 – volume: 213 start-page: 54 issue: 2 year: 2020 ident: 6625_CR1 publication-title: Med J Aust doi: 10.5694/mja2.50674 – volume: 12 start-page: 85 issue: 3 year: 2021 ident: 6625_CR39 publication-title: J Med Cases doi: 10.14740/jmc3637 – volume: 27 start-page: 9 issue: 1 year: 2021 ident: 6625_CR56 publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.09.025 – year: 2021 ident: 6625_CR2 publication-title: Am J Emerg Med doi: 10.1016/j.ajem.2021.01.074 – volume: 14 start-page: e241663 issue: 4 year: 2021 ident: 6625_CR18 publication-title: BMJ Case Rep doi: 10.1136/bcr-2021-241663 – volume: 26 start-page: 944 issue: 7 year: 2020 ident: 6625_CR58 publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2019.11.021 – volume: 37 start-page: e40 issue: 2 year: 2021 ident: 6625_CR38 publication-title: Ophthal Plast Reconstr Surg doi: 10.1097/IOP.0000000000001889 – ident: 6625_CR29 doi: 10.1177/11206721211009450 – volume: 127 start-page: 22 issue: 1 year: 2002 ident: 6625_CR8 publication-title: Otolaryngol Head Neck Surg doi: 10.1067/mhn.2002.126587 – volume: 27 start-page: 147 issue: 1 year: 2021 ident: 6625_CR3 publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.07.047 – volume: 54 start-page: S23 year: 2012 ident: 6625_CR7 publication-title: Clin Infect Dis doi: 10.1093/cid/cir866 – volume: 12 start-page: 1 issue: 9 year: 2020 ident: 6625_CR12 publication-title: Cureus – volume: 7 start-page: 174 issue: 3 year: 2021 ident: 6625_CR41 publication-title: J Fungi doi: 10.3390/jof7030174 – volume: 53 start-page: 746 issue: 6 year: 2020 ident: 6625_CR48 publication-title: Clin Endosc doi: 10.5946/ce.2020.180 – ident: 6625_CR20 doi: 10.1007/s12070-021-02574-0 – volume: 16 start-page: 1 year: 2020 ident: 6625_CR52 publication-title: Infection – volume: 19 start-page: 1 year: 2021 ident: 6625_CR13 publication-title: Mycopathologia – volume: 2021 start-page: e13663 year: 2021 ident: 6625_CR24 publication-title: Transpl Infect Dis doi: 10.1111/tid.13663 |
SSID | ssj0017829 |
Score | 2.4069538 |
SecondaryResourceType | review_article |
Snippet | COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial... Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed... Abstract Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 906 |
SubjectTerms | Biopsy Case Report Case reports Case studies Complications and side effects Coronaviruses Corticoids Corticosteroids COVID-19 Debridement Diabetes Diabetes Mellitus Disease Dosage and administration Fungal infections Fungi Health services Humans Hyphae Infections Infectious diseases Invasive Fungal Infections - diagnosis Invasive Fungal Infections - drug therapy Laboratories Literature reviews Lungs Male Methylprednisolone Middle Aged Mortality Mucormycosis Mucormycosis - diagnosis Mucormycosis - drug therapy Mycology Oxygen saturation Patient outcomes Patients Physicians Polymerase chain reaction Respiratory distress syndrome Rhizopus oryzae Risk factors SARS-CoV-2 Septum Sinuses Steroids Viral diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s1CQQYhcUBW48RObG5LoWqRSiWgVW-W4weN1CZVszn0H_RnM5Nkw0YIuHBdT6LszHhmPnv8mZA3PHoVvMwYsqczob1mNkjJohQxuCJTTuNB4cMv-f6x-HwqTzeu-sKesIEeeFDcjhdl4DpqD4lSQG5RFoFUkFwlpUrSgNEXct4aTI37B5D39PqIjMp3WojChWbYjoCM55JlszTUs_X_HpM3ktK8YXIjA-3dI3fH0pEuh0--T26F-gG5fThujj8kN0vqICfRYRuANpFenVV1w6LFZXF60QHQvLh2TVu1tKqppYD82bD2Wjk6EqxSXJilu0cnBx8Z1-9B6hfXMx3OueCbzyc2ZmprT93A8kS7S1xAeESO9z59391n40ULzOUZXzFXxqCCcqXPQd3ScVm6aH2RFbZEhAhW5mkRMyGTEGKAGhDG09xaQIcyDWn2mGzBJ4enhEbpSuWFS-FNAmKX9donBSB2mwjhQ74gfK1340YWcrwM49z0aETlZrCVAVuZ3lYmW5B30zOXAwfHX6U_oDknSeTP7n8ArzKjV5l_edWCvEZnMMiQUWMLzg_bta05ODoxS4BYUIZC6fknoW9fZ0JvR6HYwB91djz2AOpC5q2Z5PZMEua5mw-vHdOMcaY1EHBBzVwrviCvpmF8Envn6tB0KJNr3O3NQebJ4MeTcpDvUQNGXpBi5uEz7c1H6uqsZyFXCP21fPY_1P2c3En7yQlzNNsmW6urLryAYm9Vvuzn9U-ErlAl priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4t1AQQYhcUBWN4md2FzQUqhapFIJaLU3y_GjXalNls3ugX_Az2Ym8aaNEL3G4yjxvMfjz4S8TYOT3omcIXo648opZrwQLAgevC1zaRUeFD76Vhyc8K8zMYsFtza2VW5sYmeoXWOxRr4LosXBkCqZflz8YnhrFO6uxis0bpM7CF2GUl3OhoQrBe-nNgdlZLHbgi0uFcOmBMQ9FywfOaMOs_9fy3zNNY3bJq_5of0H5H4MIOm05_hDcsvXj8jdo7hF_pj8mVILnon2mwG0CXR5Pq8bFgwWx-nlGtLNy9-2aectndfUUMj_WV-BnVsaYVYplmfp3vHp4WeWqg9AdYX4TPvTLvjmiwGTmZraUdtjPdH1AssIT8jJ_pefewcsXrfAbJGnK2ar4KWXtnKF45WwqahsMK7MS1Nhngi8TrMy5FxMvA8eIkEYzwpjIEcUmc_yp2QLPtlvExqEraTjNoM3cbBgxik3KSFvNxPOnS8Skm7WXduIRY5XYlzoLieRhe55pYFXuuOVzhPyfpiz6JE4bqT-hOwcKBFFu3vQLM90VEoNv-lTFZSDIIxD3CINJulepHJSyUnmE_IGhUEjTkaNjThnZt22-vD4VE8h0YJgFALQ_xH9-D4ieheJQgM_ak08_ADLhfhbI8qdESVoux0PbwRTR2vT6ivdSMjrYRhnYgdd7Zs10hQK93wLoHnWy_GwOIj6qCBTTkg5kvDR6o1H6vl5h0UusQCgxPObP-sFuZd1agfal--QrdVy7V9CMLeqXnUa-xer1Uip priority: 102 providerName: ProQuest |
Title | A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34479495 https://www.proquest.com/docview/2574471981 https://www.proquest.com/docview/2569382361 https://pubmed.ncbi.nlm.nih.gov/PMC8415695 https://doaj.org/article/d4be19f9d84648538a0274e5180b802e |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kaa9IO4URmUQEg_I0CR2YiMh1JZNG1I3VOg08WI5jrNV6pLRtBL7B_xszsmla8TggZc81MdRc3zutr9DyCsvTaRLRMAQPZ1xlShmnBAsFTx1NgqkVXhReHQcHk745zNxtkGadkc1A4tbUzvsJzWZz97-_HH9ERT-Q6nwMnxXgI2NFMPDBohnLliwSbbBM0XY0WDEb3YVwBuq5uLMrfN2yQ4i4CmO7SbW_FQJ5_-n0V7zWu0TlWsu6uAuuVPHlrRfCcM9suGy-2RnVO-ePyC_-tSC06LVPgHNUzq_mGY5Sw3WzenlEjLRy2ubF9OCTjNqaJZnrCrOTi2tEVgpVm7p8OT06BPz1HugugGDptVFGHzzbAXXTE2WUFvBQNHlFVYYHpLJwf634SGrOzEwGwbegtk4ddJJGydhwmNhPRHb1CRREJkYU0gQA8-P0oCLnnOpgyARxv3QGEgfhe_84BHZgr_snhCaChvLhFsf3sTBuJlEJb0IUnrT4zxxYYd4Dd-1rWHKsVvGTJfpigx1tWwalk2Xy6aDDnmzmnNVgXT8k3qAy7miRIDt8od8fq5rfdXwmc5TqUogPuMQ0kiD-bsTnuzFsue7DnmJwqARQiPDMzrnZlkU-ujkVPchB4M4FWLTvxF9HbeIXtdEaQ4fak19LwLYhdBcLcq9FiUYAtsebgRTN3qkwSIDmz0lvQ55sRrGmXi4LnP5EmlChdvBIdA8ruR4xZxGHTokakl4i3vtkWx6UcKUS6wNKPH0v2c-I7t-qZygo8Ee2VrMl-45hICLuEs2o7MInnLodcn2YP_4y7hbllO6pcbDczz4_hvF2F6C |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemIQEviP8UBhgE4gFZaxI7sZEQKh3TytZNgm3am3FsZ6u0JaVphfYN-DR8Ru6SNFuE2Nte40sU-873z3c_E_ImyJz0TkQM0dMZV04x44VgmeCZt0kkrcJG4fFuvHXAvx6JoxXyZ9kLg2WVS51YKWpXWMyRr4NocVCkSgafpj8Z3hqFp6vLKzRqsdj2578gZCs_jjaAv2_DcPPL_nCLNbcKMBtHwZzZNPPSS5u62PFU2ECkNjMuiRKTYjgEUwrCJIu46HufeXB4YDyMjYFQSIQegQ5A5d_gEWxN7EwftiUlAVhbtWzMkfF6Cbo_UQyLIBBnXbCoY_yqOwL-tQSXTGG3TPOS3du8S-40Disd1BJ2j6z4_D65OW6O5B-Q3wNqwRLS-vCBFhmdnUzygmUGk_H0bAHh7dm5LcpJSSc5NTQvclZnfCeWNrCuFNPBdLh3ONpggfoAVBcI07TursEvn7YY0NTkjtoaW4ouppi2eEgOroURj8gq_LJ_QmgmbCodtyF8iYPGNE65fuLTyPQ5dz7ukWC57to22Od4BceprmIgGeuaVxp4pSte6ahH3rfvTGvkjyupPyM7W0pE7a4eFLNj3SgBDdP0gcqUA6ePg58kDSYFvAhkP5X90PfIaxQGjbgcORb-HJtFWerR3qEeQGAHzi84vP8j-v6tQ_SuIcoKmKg1TbMFLBfifXUo1zqUoF1sd3gpmLrRbqW-2Is98qodxjexYi_3xQJpYoVnzDHQPK7luF0cRJlUEJn3SNKR8M7qdUfyyUmFfS4x4aDE06t_6yW5tbU_3tE7o93tZ-R2WG1B2InRGlmdzxb-OTiS8_RFtXsp-XHd6uIvHh2H8g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+report+of+rhino-facial+mucormycosis+in+a+non-diabetic+patient+with+COVID-19%3A+a+systematic+review+of+literature+and+current+update&rft.jtitle=BMC+infectious+diseases&rft.au=Mohammadi%2C+Faezeh&rft.au=Badri%2C+Milad&rft.au=Safari%2C+Shapoor&rft.au=Hemmat%2C+Nima&rft.date=2021-09-03&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=21&rft_id=info:doi/10.1186%2Fs12879-021-06625-3&rft_id=info%3Apmid%2F34479495&rft.externalDocID=PMC8415695 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |